The effect of glucose concentrations in the medium on expression of insulin receptors in human lymphocytes B and T: an in vitro study

References

• Vasto S, Candore G, Balistreri CR, Caruso M, Colonna-Romano G, Grimaldi MP, Listi F, Nuzzo D, Lio D, Caruso C. Inflammatory networks in ageing, age-related diseases and longevity. Mech Ageing Dev 2007, 128, 83–91.
   PubMed Web of Science ®Google Scholar
• Frauwirth KA, Thompson CB. Regulation of T lymphocyte metabolism. J Immunol 2004, 172, 4661–4665.
   PubMed Web of Science ®Google Scholar
• Carbó R, Guarner V. Insulin effect on glucose transport in thymocytes and splenocytes from rats with metabolic syndrome. Diabetol Metab Syndr 2010, 2, 64.
   Google Scholar
• Aulwurm UR, Brand KA. Increased formation of reactive oxygen species due to glucose depletion in primary cultures of rat thymocytes inhibits proliferation. Eur J Biochem 2000, 267, 5693–5698.
   Google Scholar
• Doughty CA, Bleiman BF, Wagner DJ, Dufort FJ, Mataraza JM, Roberts MF, Chiles TC. Antigen receptor-mediated changes in glucose metabolism in B lymphocytes: role of phosphatidylinositol 3-kinase signaling in the glycolytic control of growth. Blood 2006, 107, 4458–4465.
   PubMed Web of Science ®Google Scholar
• DeFronzo RA. Lilly lecture 1987. The triumvirate: beta-cell, muscle, liver. A collusion responsible for NIDDM. Diabetes 1988, 37, 667–687.
   PubMed Web of Science ®Google Scholar
• Mueckler M. Glucose transport and glucose homeostasis: a new insights from transgenic mice. News Physiol Sci 1995, 10, 22–29.
   Google Scholar
• Fu Y, Maianu L, Melbert BR, Garvey WT. Facilitative glucose transporter gene expression in human lymphocytes, monocytes, and macrophages: a role for GLUT isoforms 1, 3, and 5 in the immune response and foam cell formation. Blood Cells Mol Dis 2004, 32, 182–190.
   PubMed Web of Science ®Google Scholar
• Joshi N, Caputo GM, Weitekamp MR, Karchmer AW. Infections in patients with diabetes mellitus. N Engl J Med 1999, 341, 1906–1912.
   PubMed Web of Science ®Google Scholar
• Otton R, Mendonça JR, Curi R. Diabetes causes marked changes in lymphocyte metabolism. J Endocrinol 2002, 174, 55–61.
   Google Scholar
• Oleszczak B, Szablewski L, Pliszka M. The effect of hyperglycemia and hypoglycemia on glucose transport and expression of glucose transporters in human lymphocytes B and T: an in vitro study. Diabetes Res Clin Pract 2012, 96, 170–178.
   PubMed Web of Science ®Google Scholar
• Szablewski L, Oleszczak B, Mrozikiewicz-Rakowska B, Karnafel W, Grytner-Zięcina B. Deoxy-D-glucose transport into lymphocytes, granulocytes and erythrocytes in patients with type 2 diabetes mellitus. Exptl Clin Diabetol 2007, 7, 245–255.
   Google Scholar
• Mello KF, Lunardelli A, Donadio MVF, Caberlon E, Oliveira CSA, Bastos CMA et al. Immunomodulatory effects of oral antidiabetic drugs in lymphocyte cultures from patients with type 2 diabetes. J Bras Patol Med Lab 2011, 47, 43–48.
   Google Scholar
• Maciver NJ, Jacobs SR, Wieman HL, Wofford JA, Coloff JL, Rathmell JC. Glucose metabolism in lymphocytes is a regulated process with significant effects on immune cell function and survival. J Leukoc Biol 2008, 84, 949–957.
   PubMed Web of Science ®Google Scholar
• Zhao FQ, Keating AF. Functional properties and genomics of glucose transporters. Curr Genomics 2007, 8, 113–128.
   PubMed Web of Science ®Google Scholar
• Maratou E, Dimitriadis G, Kollias A, Boutati E, Lambadiari V, Mitrou P, Raptis SA. Glucose transporter expression on the plasma membrane of resting and activated white blood cells. Eur J Clin Invest 2007, 37, 282–290.
   PubMed Web of Science ®Google Scholar
• Stentz FB, Kitabchi AE. De novo emergence of growth factor receptors in activated human CD4+ and CD8+ T lymphocytes. Metab Clin Exp 2004, 53, 117–122.
   PubMed Web of Science ®Google Scholar
• Chen L. A literature review of intensive insulin therapy and mortality in critically ill patients. Clin Nurse Spec 2010, 24, 80–86.
   PubMed Web of Science ®Google Scholar
• Ito T, Otsuki M, Igarashi H, Kihara Y, Kawabe K, Nakamura T, Fujimori N, Oono T, Takayanagi R, Shimosegawa T; Research Committee of Intractable Diseases of the Pancreas. Epidemiological study of pancreatic diabetes in Japan in 2005: a nationwide study. Pancreas 2010, 39, 829–835.
   Google Scholar
• Swinnen SG, Dain MP, Aronson R, Davies M, Gerstein HC, Pfeiffer AF, Snoek FJ, Devries JH, Hoekstra JB, Holleman F. A 24-week, randomized, treat-to-target trial comparing initiation of insulin glargine once-daily with insulin detemir twice-daily in patients with type 2 diabetes inadequately controlled on oral glucose-lowering drugs. Diabetes Care 2010, 33, 1176–1178.
   PubMed Web of Science ®Google Scholar
• Stentz FB, Kitabchi AE. Activated T lymphocytes in Type 2 diabetes: implications from in vitro studies. Curr Drug Targets 2003, 4, 493–503.
   PubMed Web of Science ®Google Scholar
• Stentz FB, Kitabchi AE. Hyperglycemia-induced activation of human T-lymphocytes with de novo emergence of insulin receptors and generation of reactive oxygen species. Biochem Biophys Res Commun 2005, 335, 491–495.
   PubMed Web of Science ®Google Scholar
• Denley A, Carroll JM, Brierley GV, Cosgrove L, Wallace J, Forbes B, Roberts CT Jr. Differential activation of insulin receptor substrates 1 and 2 by insulin-like growth factor-activated insulin receptors. Mol Cell Biol 2007, 27, 3569–3577.
   PubMedGoogle Scholar
• Viardot A, Grey ST, Mackay F, Chisholm D. Potential antiinflammatory role of insulin via the preferential polarization of effector T cells toward a T helper 2 phenotype. Endocrinology 2007, 148, 346–353.
   PubMed Web of Science ®Google Scholar
• Musa BOP, Onyemelukwe GC, Hambolu JO, Bakari AG, Anumah FE. Cell mediated immunity in Type 2 diabetes mellitus patients in diabetic ketoacidosis, patients with controlled Type 2 diabetes mellitus and healthy control subjects. J Med Med Sci 2010, 1, 290–295.
   Google Scholar
• Korgun ET, Demir R, Sedlmayr P, Desoye G, Arikan GM, Puerstner P, Haeusler M, Dohr G, Skofitsch G, Hahn T. Sustained hypoglycemia affects glucose transporter expression of human blood leukocytes. Blood Cells Mol Dis 2002, 28, 152–159.
   PubMed Web of Science ®Google Scholar
• Kobayashi C, Sasaki H, Kosuge K, Miyakita Y, Hayakawa M, Suzuki A, Abe E, Suzuki K, Aizawa Y. Severe starvation hypoglycemia and congestive heart failure induced by thyroid crisis, with accidentally induced severe liver dysfunction and disseminated intravascular coagulation. Intern Med 2005, 44, 234–239.
   Google Scholar
• Bolinder J, Sjöberg S, Arner P. Stimulation of adipose tissue lipolysis following insulin-induced hypoglycaemia: evidence of increased beta-adrenoceptor-mediated lipolytic response in IDDM. Diabetologia 1996, 39, 845–853.
   Google Scholar
• Chon S, Choi MC, Lee YJ, Hwang YC, Jeong IK, Oh S, Ahn KJ, Chung HY, Woo JT, Kim SW, Kim JW, Kim YS. Autoimmune hypoglycemia in a patient with characterization of insulin receptor autoantibodies. Diabetes Metab J 2011, 35, 80–85.
   Google Scholar
• Halsall DJ, Mangi M, Soos M, Fahie-Wilson MN, Wark G, Mainwaring-Burton R, O’Rahilly S. Hypoglycemia due to an insulin binding antibody in a patient with an IgA-kappa myeloma. J Clin Endocrinol Metab 2007, 92, 2013–2016.
   PubMed Web of Science ®Google Scholar
• Otton R, Soriano FG, Verlengia R, Curi R. Diabetes induces apoptosis in lymphocytes. J Endocrinol 2004, 182, 145–156.
   PubMed Web of Science ®Google Scholar
• Kitabchi AE, Stentz FB, Umpierrez GE. Diabetic ketoacidosis induces in vivo activation of human T-lymphocytes. Biochem Biophys Res Commun 2004, 315, 404–407.
   Google Scholar
• Hanazaki K, Maeda H, Okabayashi T. Relationship between perioperative glycemic control and postoperative infections. World J Gastroenterol 2009, 15, 4122–4125.
   Google Scholar
• Palmeira CM, Rolo AP, Berthiaume J, Bjork JA, Wallace KB. Hyperglycemia decreases mitochondrial function: the regulatory role of mitochondrial biogenesis. Toxicol Appl Pharmacol 2007, 225, 214–220.
   PubMed Web of Science ®Google Scholar
• Cabeza N, Li Z, Schulz C, Kremmer E, Massberg S, Bültmann A, Gawaz M. Surface expression of collagen receptor Fc receptor-gamma/glycoprotein VI is enhanced on platelets in type 2 diabetes and mediates release of CD40 ligand and activation of endothelial cells. Diabetes 2004, 53, 2117–2121.
   PubMed Web of Science ®Google Scholar
• Dimitriadis G, Maratou E, Boutati E, Psarra K, Papasteriades C, Raptis SA. Evaluation of glucose transport and its regulation by insulin in human monocytes using flow cytometry. Cytometry A 2005, 64, 27–33.
   PubMed Web of Science ®Google Scholar
• Kasuga M, Kahn CR, Hedo JA, Van Obberghen E, Yamada KM. Insulin-induced receptor loss in cultured human lymphocytes is due to accelerated receptor degradation. Proc Natl Acad Sci USA 1981, 78, 6917–6921.
   PubMedGoogle Scholar
• Rosa SC, Rufino AT, Judas F, Tenreiro C, Lopes MC, Mendes AF. Expression and function of the insulin receptor in normal and osteoarthritic human chondrocytes: modulation of anabolic gene expression, glucose transport and GLUT-1 content by insulin. Osteoarthr Cartil 2011, 19, 719–727.
   Google Scholar
• Youngren JF. Regulation of insulin receptor function. Cell Mol Life Sci 2007, 64, 873–891.
   PubMed Web of Science ®Google Scholar
• Traxinger RR, Marshall S. Glucose regulation of insulin receptor affinity in primary cultured adipocytes. J Biol Chem 1990, 265, 18879–18883.
   Google Scholar
• Rothenberg PL, Willison LD, Simon J, Wolf BA. Glucose-induced insulin receptor tyrosine phosphorylation in insulin-secreting beta-cells. Diabetes 1995, 44, 802–809.
   PubMedGoogle Scholar
• Pillay TS, Xiao S, Olefsky JM. Glucose-induced phosphorylation of the insulin receptor. Functional effects and characterization of phosphorylation sites. J Clin Invest 1996, 97, 613–620.
   PubMed Web of Science ®Google Scholar
• Ide R, Maegawa H, Kikkawa R, Shigeta Y, Kashiwagi A. High glucose condition activates protein tyrosine phosphatases and deactivates insulin receptor function in insulin-sensitive rat 1 fibroblasts. Biochem Biophys Res Commun 1994, 201, 71–77.
   Google Scholar